Lixte Biotechnology requests withdrawal of registration statement

Lixte Biotechnology (LIXT) announced that it has filed a request for withdrawal with the SEC of the company’s Registration Statement on Form S-1 (No. 333-282781), as amended, originally filed on October 23, 2024, as the company no longer intends to pursue a public offering under the Registration Statement at this time. The Registration Statement has not been declared effective by the SEC, and no securities have been sold in connection with the offering described in the Registration Statement.